| Understanding the effectiveness of government interventions against the resurgence of COVID-19 in Europe M Sharma, S Mindermann, C Rogers-Smith, G Leech, B Snodin, J Ahuja, ... Nature communications 12 (1), 5820, 2021 | 130* | 2021 |
| RNA vaccines: a suitable platform for tackling emerging pandemics? JB Sandbrink, RJ Shattock Frontiers in Immunology 11, 608460, 2020 | 59 | 2020 |
| Mask wearing in community settings reduces SARS-CoV-2 transmission G Leech, C Rogers-Smith, JT Monrad, JB Sandbrink, B Snodin, R Zinkov, ... Proceedings of the National Academy of Sciences 119 (23), e2119266119, 2022 | 33* | 2022 |
| Promoting versatile vaccine development for emerging pandemics JT Monrad, JB Sandbrink, NG Cherian npj Vaccines 6 (1), 26, 2021 | 26 | 2021 |
| Biosecurity risks associated with vaccine platform technologies JB Sandbrink, GD Koblentz Vaccine 40 (17), 2514-2523, 2022 | 12 | 2022 |
| Biosecurity in an age of open science JA Smith, JB Sandbrink PLoS Biology 20 (4), e3001600, 2022 | 9* | 2022 |
| Rapid proliferation of pandemic research: implications for dual-use risks S Musunuri, JB Sandbrink, JT Monrad, MJ Palmer, GD Koblentz Mbio 12 (5), e01864-21, 2021 | 9 | 2021 |
| Protocols and risks: when less is more J Pannu, JB Sandbrink, M Watson, MJ Palmer, DA Relman Nature protocols 17 (1), 1-2, 2022 | 8 | 2022 |
| Altered glycolysis triggers impaired mitochondrial metabolism and mTORC1 activation in diabetic β-cells E Haythorne, M Lloyd, J Walsby-Tickle, AI Tarasov, J Sandbrink, I Portillo, ... Nature Communications 13 (1), 6754, 2022 | 5 | 2022 |
| Safety and security concerns regarding transmissible vaccines JB Sandbrink, MC Watson, AM Hebbeler, KM Esvelt Nature Ecology & Evolution 5 (4), 405-406, 2021 | 5 | 2021 |
| Insidious Insights: Implications of viral vector engineering for pathogen enhancement JB Sandbrink, EC Alley, MC Watson, GD Koblentz, KM Esvelt Gene Therapy, 1-4, 2022 | 3 | 2022 |
| A dataset of non-pharmaceutical interventions on SARS-CoV-2 in Europe G Altman, J Ahuja, JT Monrad, G Dhaliwal, C Rogers-Smith, G Leech, ... Scientific Data 9 (1), 145, 2022 | 2 | 2022 |
| Mitigating Biosecurity Challenges of Wildlife Virus Discovery J Sandbrink, J Ahuja, J Swett, G Koblentz, C Standley | 2* | 2022 |
| Differential technology development: A responsible innovation principle for navigating technology risks J Sandbrink, H Hobbs, J Swett, A Dafoe, A Sandberg Available at SSRN, 2022 | 1 | 2022 |
| Innovating Respirators: PPE Lessons for Global Catastrophic Biological Risks NX Montazeri, JB Sandbrink ScienceOpen Preprints, 2022 | | 2022 |
| Glucose metabolites upstream of glyceraldehyde 3-phosphate dehydrogenase trigger activation of the mechanistic target of rapamycin complex 1 pathway in diabetic islets E Haythorne, M Lloyd, J Walsby-Tickle, J Sandbrink, G Cyranka, ... DIABETOLOGIA 65 (SUPPL 1), S17-S17, 2022 | | 2022 |
| Downregulation of glyceraldehyde 3-phoshate dehydrogenase triggers hyperactivation of the mechanistic target of rapamycin complex 1 pathway in diabetic islets E Haythorne, M Lloyd, J Walsby-Tickle, J Sandbrink, RT Exposito, ... DIABETIC MEDICINE 39, 2022 | | 2022 |
| Inhibition of mTORC1 partially restores hyperglycaemia-associated mitochondrial dysfunction in pancreatic islets E Haythorne, RT Exposito, J Sandbrink, FM Ashcroft DIABETIC MEDICINE 38, 2021 | | 2021 |
| Refining global maps of G6PD deficiency: harnessing new data and analytical methods DA Pfeffer, TC Lucas, C Johnston, J Wei, J Sandbrink, B Ley, A Clements, ... American Journal of Tropical Medicine and Hygiene 101 (5_Suppl), 2019 | | 2019 |
Joshua Teperowski MonradOxford UniversityVerified email at philosophy.ox.ac.uk
